Phadia Recalls ImmunoCAP Allergen c6 Amoxicilloyl Due to Stability Failures
Phadia US Inc is recalling 950 units of ImmunoCAP Allergen c6, Amoxicilloyl because the product failed to meet stability specifications.
The agency’s classification
FDA (Devices): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, but the source text does not report any illnesses, injuries, or hospitalizations. The hazard is a failure to meet stability specifications, which is a quality control issue without reported adverse health consequences, fitting the criteria for a moderate severity score.
Plain-English summary
Phadia US Inc is recalling 950 units of ImmunoCAP Allergen c6, Amoxicilloyl (Article number 14-4451-016). The product is an in vitro quantitative assay used to measure allergen-specific IgE in human serum or plasma. It is intended for use with Phadia 250, Phadia 1000, Phadia 2500, and Phadia 5000 instruments.
The recall was initiated because the stability specifications of the ImmunoCAP Allergen c6, Amoxicilloyl were not met. The affected lots are 991DA (exp. 2018.04.30), 991DC (exp. 2018.07.31), 991D7, and 991D9 (exp. 2018.02.28). The product was distributed nationwide.
Healthcare facilities and laboratories should stop using the affected product and contact Phadia US Inc for further instructions. Consumers should not use the product if they have it in their possession.
The recalled product
- Product
- ImmunoCAP Allergen c6, Amoxicilloyl ( Article number 14-4451-016). ImmunoCAP Specific IgE is an in vitro quantitative assay for the measurement of allergen specific IgE in human serum or plasma; to be used with the instrument Phadia 250, Phadia 1000, Phadia 2500 and Phadia…
- Manufacturer
- Phadia US Inc
- Hazard
- Affected units
- 950
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lots 991DA
- exp.2018.04.30 991DC
- exp. 2018.07.31 991D7 991D9
- exp.2018.02.28
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 2 recalled by Phadia US Inc under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · Phadia US Inc
See all →- ModerateDiagnostic Test Well Shows Inconsistent Results on Phadia 2500EE
FDA (Devices) · 2023-07-05
- ModeratePhadia 2500EE diagnostic instrument recalled for measurement inaccuracy
FDA (Devices) · 2023-07-05
- ModeratePhadia Recalls EliA dsDNA Well Kits Due to Potential False Positive Results
FDA (Devices) · 2021-02-17
- ModeratePhadia Recalls ImmunoCAP Allergen c5 Ampicilloyl Test Kits
FDA (Devices) · 2018-04-11
- HighPhadia 1000 Instrument Recalled Due to Retry Command Malfunction
FDA (Devices) · 2018-01-24
Same hazard · stability failure
See all →- ModerateSafecor Health Recalls Fluphenazine HCl Elixir Due to Stability Failures
FDA (Drugs) · 2026-09-23
- ModerateSafecor Health Recalls Fluphenazine HCl Elixir Due to Stability Failures
FDA (Drugs) · 2026-09-23
- ModerateSafecor Health Recalls Fluphenazine HCl Elixir Due to Stability Failures
FDA (Drugs) · 2026-09-23
- ModerateSafecor Health Recalls Fluphenazine HCl Elixir Due to Stability Failures
FDA (Drugs) · 2026-09-23
- ModerateSafecor Health Recalls Fluphenazine HCl Elixir Due to Stability Failures
FDA (Drugs) · 2026-09-23
Similar recalls
- ModeratePhadia 2500EE diagnostic instrument recalled for measurement inaccuracy
FDA (Devices) · 2023-07-05
- ModeratePhadia 1000 Instrument Recalled for Rack Sequencing Error
FDA (Devices) · 2015-01-21
- ModeratePhadia 1000 Immunodiagnostic Instruments Recalled for Liquid Sensor Error
FDA (Devices) · 2019-09-04
- ModeratePhadia Recalls EliA dsDNA Well Kits Due to Potential False Positive Results
FDA (Devices) · 2021-02-17
- LowPhadia Varelisa Cardiolipin IgM Test Kits Recalled for Elevated Results
FDA (Devices) · 2012-09-05
- ModeratePhadia EliA RF IgM Well Recalled for Potential Low Assay Results
FDA (Devices) · 2019-07-10